VitaSeq is a biotechnology company and spin-off from the German Center for Neurodegenerative Diseases (DZNE), focused on the development of blood-based molecular diagnostics for neurodegenerative diseases
VitaSeq is a biotechnology company and spin-off from the German Center for Neurodegenerative Diseases (DZNE), focused on the development of blood-based molecular diagnostics for neurodegenerative diseases. The company's platform leverages a proprietary microRNA biomarker panel to characterize systemic molecular signatures associated with brain health and neurodegenerative processes. This approach enables the assessment of biological changes that occur prior to the onset of clinical symptoms, supporting early identification and risk stratification in Alzheimer's disease. VitaSeq's technology is designed to complement established diagnostic approaches and to support applications in patient stratification, clinical research, and therapeutic development.